The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 05, 2016
Filed:
Sep. 29, 2009
Marie-thérèse Paternostre, Verrières le Buisson, FR;
Jean-christophe Cintrat, Igny, FR;
Céline Valery, Barelone, ES;
Stéphane Roux, Nice, FR;
Bernard Rousseau, Levallois Perret, FR;
Maarten Ijsselstijn, Groningen, NL;
Roland Cherif-cheikh, Castelldefels, ES;
Franck Artzner, Cesson Sevigne, FR;
Marie-Thérèse Paternostre, Verrières le Buisson, FR;
Jean-Christophe Cintrat, Igny, FR;
Céline Valery, Barelone, ES;
Stéphane Roux, Nice, FR;
Bernard Rousseau, Levallois Perret, FR;
Maarten Ijsselstijn, Groningen, NL;
Roland Cherif-Cheikh, Castelldefels, ES;
Franck Artzner, Cesson Sevigne, FR;
IPSEN PHARMA S.A.S., Boulogne-Billancourt, FR;
COMMISSARIAT A L'ENERGIE ATOMIQUE (CEA), Paris, FR;
LE CENTRE NATIONAL DE RECHERCHE SCIENTIFIQUE (CNRS), Paris, FR;
Abstract
The present invention relates to novel octapeptide compounds of general formula (I): H-2-Nal-cyclo(Cys-Tyr-AA-Lys-Val-Cys)-Thr-NH. Since these products have a good affinity for certain somatostatin receptor subtypes, they are particularly advantageous for treating pathological states or diseases in which one (or more) somatostatin receptor(s) is (are) involved. These compounds furthermore have physiochemical properties that make it possible to envisage them in diverse solutions for the formulation of medicaments, for example as a pharmaceutically acceptable carrier. The invention also relates to pharmaceutical compositions containing said products and to the use thereof for the preparation of a medicament.